Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Jul, 2018 | Pages:
55 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)
The global continuous glucose monitoring (CGM) devices market size is expected to reach USD 1.01 billion by 2024, according to a new report by Grand View Research, Inc. The market is estimated to register a CAGR of 13.7% over the forecast period. Growing cases of diabetes and introduction of novel and advanced diabetes care devices are the major factors driving the market growth. Continuous glucose monitoring devices provide an efficient method to measure body glucose levels in real time. Data recorded by these devices is transmitted through a wireless network to receivers; this helps keep a track of glucose levels over a designated period. These devices also help manage diabetes while reducing individual insulin dosages. Integrated software within these devices provides users with insights about food consumption, medication, physical activity, and illnesses. Thus, an increasing number of diabetic patients are using these devices to manage and treat diabetes, which, in turn, is accelerating market growth. With the advent of digital therapeutics, a rising number of CGM devices are being incorporated with apps and software to help patients with diabetes mellitus. Rise in the number of diabetes mellitus has been contributing toward market growth. Further key findings from the study suggest: • Growing cases of diabetes is anticipated to propel market growth, with increasing number of patients opting for simplified CGM devices • CGM devices provide analysis of blood glucose levels from the tissue fluid at regular intervals of time, which is also driving their demand • Transmitters and receivers was the largest component type segment and is anticipated to maintain its dominance owing to their integral nature in these devices • Insulin pumps are anticipated to witness the highest CAGR during the forecast period due to their ability to maintain optimal blood glucose levels • Asia Pacific is the leading regional market, with Japan, China, and India on the forefront • North America led the global market in the past owing to wide usage of CGM devices as a result of higher number of target patients in the region • The European region followed the North American closely in terms of market revenue due to rise in the adoption of these devices in key countries such as U.K., Germany, France, Italy, and Spain • Some of the key companies present in the market are Pfizer Inc.; Baxter International, Inc.; Abbott Laboratories; Medtronic PLC; Animas Corporation; and Novo Nordisk A/S.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
Chapter 2. Executive Summary
2.1. Continuous Glucose Monitoring Devices Market - Industry Summary and Key Buying Criteria, 2013 - 2024
Chapter 3. Continuous Glucose Monitoring Devices Industry Outlook
3.1. Market segmentation
3.2. Market size and growth prospects, 2013 - 2024
3.3. Continuous Glucose Monitoring Devices: Market dynamics
3.3.1. Market driver analysis
3.3.1.1. Increasing number of diabetes patients globally
3.3.1.2. Easy and efficient monitoring of current glucose values
3.3.2. Market restraint analysis
3.3.2.1. High surge in the price and cost of treatment
3.4. Continuous Glucose Monitoring Devices Market: Industry trend analysis
3.5. Continuous Glucose Monitoring Devices Market: PESTEL Analysis
3.6. Continuous Glucose Monitoring Devices Industry Analysis - Porter's Five Forces Model
3.7. Continuous Glucose Monitoring Devices: Company market share analysis (%), 2015
3.8. Key opportunities prioritized
Chapter 4. Continuous Glucose Marketing Product Outlook
4.1. Continuous Glucose Monitoring Revenue Share (%) Analysis, by Product, 2016 & 2024
4.2. Transmitters and Receivers
4.2.1. Transmitters and receivers market revenue, by region, 2013 to 2024 (USD Million)
4.3. Sensors
4.3.1. Sensors market revenue, by region, 2013 to 2024 (USD Million)
4.4. Insulin Pumps
4.4.1. Insulin pumps market revenue, by region, 2013 to 2024 (USD Million)
Chapter 5. Continuous Glucose Monitoring end - user Outlook
5.1. Continuous Glucose Monitoring Revenue Share (%) Analysis, by end - user, 2016 & 2024
5.2. Hospital
5.2.1. Hospital market revenue, by region, 2013 to 2024 (USD Million)
5.3. Homecare Diagnostics
5.3.1. Homecare diagnostics market revenue, by region, 2013 to 2024 (USD Million)
5.4. Others
5.4.1. Others market revenue, by region, 2013 to 2024 (USD Million)
Chapter 6. Continuous Glucose Monitoring Regional Outlook
6.1. Continuous Glucose Monitoring Market Share (%) Analysis, by Region, 2014 & 2024
6.2. North America
6.2.1. U.S.
6.2.1.1. continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
6.2.1.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)
6.2.2. Canada
6.2.2.1. continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
6.2.2.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)
6.3. Europe
6.3.1. Germany
6.3.1.1. continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
6.3.1.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)
6.3.2. U.K.
6.3.2.1. continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
6.3.2.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)
6.4. Asia Pacific
6.4.1. China
6.4.1.1. continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
6.4.1.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)
6.4.2. India
6.4.2.1.continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
6.4.2.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)
6.5. MEA
6.5.1. South Africa
6.5.1.1. continuous glucose monitoring devices market, by product application, 2013 - 2024 (USD Million)
6.5.1.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)
6.5.2. Saudi Arabia
6.5.2.1. continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
6.5.2.2. continuous glucose monitoring devices market, by end - user application, 2013 - 2024 (USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
6.6.1.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)
6.6.2. Mexico
6.6.2.1. continuous glucose monitoring devices market, by product, 2013 - 2024 (USD Million)
6.6.2.2. continuous glucose monitoring devices market, by end - user, 2013 - 2024 (USD Million)
Chapter 7. Competitive Landscape
7.1. Roche Diagnostics
7.1.1. Company Overview
7.1.2. Financial Performance
7.1.3. Product Benchmarking
7.1.4. Strategic Initiatives
7.2. Dexcom Inc.
7.2.1. Company Overview
7.2.2. Financial Performance
7.2.3. Product Benchmarking
7.2.4. Strategic Initiatives
7.3. Abbott Laboratories
7.3.1. Company Overview
7.3.2. Financial Performance
7.3.3. Product Benchmarking
7.3.4. Strategic Initiatives
7.4. Medtronic Inc.
7.4.1. Company Overview
7.4.2. Financial Performance
7.4.3. Product Benchmarking
7.4.4. Strategic Initiatives
7.5. Animas Corporation
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Product Benchmarking
7.5.4 Strategic Initiatives
7.6. Novo Nordisk
7.6.1. Company Overview
7.6.2. Financial Performance
7.6.3. Product Benchmarking
7.6.4. Strategic Initiatives
7.7. Ypsomed AG
7.7.1. Company Overview
7.7.2. Financial Performance
7.7.3. Product Benchmarking
7.7.4. Strategic Initiatives
7.8. GlySens Incorporated
7.8.1. Company Overview
7.8.2. Financial Performance
7.8.3. Product Benchmarking
7.8.4. Strategic Initiatives
List of Tables 1. Continuous Glucose Monitoring Devices - Industry Snapshot & Key Buying Criteria, 2013 - 2024 2. Continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million) 3. Continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million) 4. Continuous glucose monitoring devices market, by region, 2013 - 2024 (USD Million) 5. Continuous glucose monitoring devices - Key Market Driver Analysis 6. Continuous glucose monitoring devices - Key Market Restraint Analysis 7. North America continuous glucose monitoring devices market revenue, 2013 - 2024 (USD Million) 8. U.S. continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million) 9. U.S. continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million) 10. Canada continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million) 11. Canada continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million) 12. Europe continuous glucose monitoring devices market revenue, 2013 - 2024 (USD Million) 13. Germany continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million) 14. Germany continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million) 15. U.K. continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million) 16. U.K. continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million) 17. Asia Pacific continuous glucose monitoring devices market revenue, 2013 - 2024 (USD Million) 18. China continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million) 19. China continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million) 20. India continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million) 21. India continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million) 22. Latin America continuous glucose monitoring devices market revenue, 2013 - 2024 (USD Million) 23. Brazil continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million) 24. Brazil continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million) 25. Mexico continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million) 26. Mexico continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million) 27. MEA continuous glucose monitoring devices market revenue, 2013 - 2024 (USD Million) 28. South Africa continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million) 29. South Africa continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million) 30. Saudi Arabia continuous glucose monitoring devices market revenue, by product, 2013 - 2024 (USD Million) 31. Saudi Arabia continuous glucose monitoring devices market revenue, by end - user, 2013 - 2024 (USD Million) List of Figures 1. Continuous glucose monitoring devices: Market segmentation 2. Continuous glucose monitoring devices, 2013 - 2024 (USD Million) 3. Continuous glucose monitoring devices market: Industry trend analysis 4. Continuous glucose monitoring devices market: PESTEL analysis 5. Continuous glucose monitoring devices market: Porter's analysis 6. Continuous glucose monitoring devices company market share, 2015 7. Key Opportunities Prioritized 8. Continuous glucose monitoring devices market revenue share by product, 2016 & 2024 9. Transmitters and receivers market revenue, 2013 to 2024 (USD Million) 10. Sensors market revenue, 2013 to 2024 (USD Million) 11. Insulin pumps market revenue, 2013 to 2024 (USD Million) 12. Continuous glucose monitoring devices market revenue share end user, 2016 & 2024 13. Hospital market revenue, 2013 to 2024 (USD Million) 14. Homecare Diagnostics market revenue, 2013 to 2024 (USD Million) 15. Diagnostic Centers market revenue, 2013 to 2024 (USD Million) 16. Others market revenue, 2013 to 2024 (USD Million) 17. Continuous glucose monitoring devices market share, by region, 2016 & 2024
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
